Evidence map›Paper›PMID 38783191›Full record

ArticleThe journal of headache and pain2024

MERTK in the rat trigeminal system: a potential novel target for cluster headache?

Jacob C A Edvinsson, Caroline Ran, Felicia Jennysdotter Olofsgård, Anna Steinberg, Lars Edvinsson, Andrea Carmine Belin

Abstract read
In one paragraph

Article in The journal of headache and pain, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Hallmarks of primary headache: part 3 - cluster headache.The journal of headache and pain · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jacob C A Edvinsson *Department of Internal Medicine, Lund University, Sölvegatan 19, Lund, 22184, Sweden. Jacob.Edvinsson@med.lu.se.
Caroline Ran *Centre for Cluster Headache, Department of Neuroscience, Karolinska Institutet, Stockholm, 17177, Sweden.
Felicia Jennysdotter OlofsgårdCentre for Cluster Headache, Department of Neuroscience, Karolinska Institutet, Stockholm, 17177, Sweden.
Anna SteinbergDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, 17177, Sweden.
Lars Edvinsson *Department of Internal Medicine, Lund University, Sölvegatan 19, Lund, 22184, Sweden.
Andrea Carmine Belin *Centre for Cluster Headache, Department of Neuroscience, Karolinska Institutet, Stockholm, 17177, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The trigeminal system is key to the pathophysiology of migraine and cluster headache, two primary headache disorders that share many features. Recently, MER proto-oncogene tyrosine kinase (MERTK), a cell surface receptor, was strongly associated with cluster headache through genetic studies. Further, the MERTK ligand galectin-3 has been found to be elevated in serum of migraine patients. In this study, MERTK and MERTK ligands were investigated in key tissue to better understand their potential implication in the pathophysiology of primary headache disorders. Immunohistochemistry was used to map MERTK and galectin-3 expression in rat trigeminal ganglia. RT-qPCR was used to assess MERTK gene expression in blood, and ELISA immunoassays were used for MERTK ligand quantification in serum from study participants with and without cluster headache. MERTK gene expression was elevated in blood samples from study participants with cluster headache compared to controls. In addition, MERTK ligand galectin-3 was found at increased concentration in the serum of study participants with cluster headache, whereas the levels of MERTK ligands growth arrest specific 6 and protein S unaffected. MERTK and galectin-3 were both expressed in rat trigeminal ganglia. Galectin-3 was primarily localized in smaller neurons and to a lesser extent in C-fibres, while MERTK was found in satellite glia cells and in the outer membrane of Schwann cells. Interestingly, a strong MERTK signal was found specifically in the region proximal to the nodes of Ranvier. The overexpression of MERTK and galectin-3 in tissue from study participants with cluster headache, as well as the presence of MERTK in rat peripheral satellite glia cells and Schwann cells in the trigeminal ganglia, further highlights MERTK signalling as an interesting potential future therapeutic target in primary headache.

Indexed as

Cluster Headachec-Mer Tyrosine KinaseTrigeminal GanglionAdultAnimalsBlood ProteinsFemaleGalectinsHumansMaleMiddle AgedProto-Oncogene MasRatsRats, Sprague-DawleyReceptor Protein-Tyrosine KinasesBlood Proteinsc-Mer Tyrosine KinaseGalectinsLGALS3 protein, humanMAS1 protein, humanMERTK protein, humanMertk protein, ratProto-Oncogene MasReceptor Protein-Tyrosine KinasesGalectin-3GWASMER proto-oncogene tyrosine kinaseMigraineTrigeminal system

Identifiers

PMID38783191
PMCPMC11119394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.